Product information

From Health Canada

New search

The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.

Current status:

Approved

Current status date:

2020-06-03

Product name:

ERADIA

Help on accessing alternative formats, such as Portable Document Format (PDF), Microsoft Word and PowerPoint (PPT) files, can be obtained in the alternate format help section .

DIN:

02499819

Product Monograph/Veterinary Labelling:

Date: 2020-06-03 Product monograph/Veterinary Labelling (PDF version ~ 175K)

Company: 

VIRBAC ANIMAL HEALTH INC
Po Box/Cp 162059
Fort Worth
Texas
United States  76161

Class: 

Veterinary

Species:

Dogs

Dosage form(s):

Suspension

Route(s) of administration:

Oral

Number of active ingredient(s):

1

Schedule(s):

Prescription Recommended  

Biosimilar Biologic Drug:

No

American Hospital Formulary Service (AHFS): See footnote 3

Not Applicable

Anatomical Therapeutic Chemical (ATC): See footnote 4

Not Applicable

Active ingredient group (AIG) number:See footnote 5

0102572011

List of active ingredient(s)
Active ingredient(s) Strength
METRONIDAZOLE 125 MG / ML

Application information

Related information

Contact us

Version 3.7.4
Date modified: